AEGiS-BBC: Probe into South Africa drugs recall BBC News OnlineImportant note: Information in this article was accurate in 2008. The state of the art may have changed since the publication date.
Click here to return to BBC News Online main menu
DonateNow
Print this article

Probe into South Africa drugs recall

BBC News - August 12, 2008


South Africa's health department has launched an investigation after two tuberculosis drugs used for treating thousands of patients were withdrawn.

Pharmascript, which supplied state hospitals and clinics with the medication, has promised to replace drugs found to be sub-standard.

The probe comes within days of some anti-retroviral (ARV) drugs being recalled after a packaging mix up.

HIV and Aids patients have been urged to urgently seek medical advice.

Initial tests showed that the withdrawn TB drugs lost their potency over a period of time.

"If we're getting drugs that are not of quality... we're not going to get the results that we require," Health Minister Manto Tshabalala-Msimang said.

"Further tests are being conducted on the stability of these products," she said.

People may carry the TB infection for many years but only develop the disease when they develop HIV, which suppresses the immune system.

Certain types of Nevirapine, used by HIV-positive pregnant women, and Adco-Zidovudine (AZT) were recalled by Adcock Ingram over the weekend.

According to South African HIV campaign group Treatment Action Campaign, Adcock Ingram supplies ARVs to the private sector and has recently been awarded a tender to supply medications to state hospitals.

"We are concerned that the recall will undermine public faith in the quality and safety of medicines and are worried about the potential impact that the recall will have on the availability of life-saving ARV medications."

South Africa has one of the world's highest incidences of HIV.

One in five adults are reported to be infected and an estimated 500,000 people are infected each year.


080812
BB080816


Copyright © 2008 - BBC. Reproduction of this article (other than one copy for personal reference) must be cleared through the BBC.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation UK, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 2008. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2008. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.

.